Aclaris Therapeutics, Inc. (ACRS) Operating cash flow 2016–2025
Aclaris Therapeutics, Inc. (ACRS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$47.1MFY2025 · since FY2016: -$34.6M → -$47.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$47.1M | -134.7% |
| FY2024 | -$20.1M | +74.4% |
| FY2023 | -$78.3M | -15.9% |
| FY2022 | -$67.6M | -29.6% |
| FY2021 | -$52.1M | -34.9% |
| FY2020 | -$38.6M | +59.9% |
| FY2019 | -$96.4M | +4.3% |
| FY2018 | -$100.8M | -84.4% |
| FY2017 | -$54.7M | -58.0% |
| FY2016 | -$34.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice